All Outcomes
Home COVID-19 treatment researchXiannuoxinXiannuoxin (more..)
Melatonin Meta
Metformin Meta
Azvudine Meta
Bromhexine Meta Molnupiravir Meta
Budesonide Meta
Colchicine Meta
Conv. Plasma Meta Nigella Sativa Meta
Curcumin Meta Nitazoxanide Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta


Supplementary Data — Xiannuoxin for COVID-19: real-time meta analysis of 2 studies

@CovidAnalysis, February 2024, Version 1V1
0 0.25 0.5 0.75 1 1.25 1.5 1.75 2+ Cao (DB RCT) 17% 0.83 [0.79-0.88] recov. time 504 (n) 503 (n) Improvement, RR [CI] Treatment Control Wang (DB RCT) 68% 0.32 [0.10-1.03] recovery 12 (n) 8 (n) Wang (DB RCT) 48% 0.52 [0.18-1.52] recovery 10 (n) 8 (n) Wang (DB RCT) 38% 0.62 [0.34-1.12] viral load 12 (n) 8 (n) Wang (DB RCT) 14% 0.86 [0.47-1.57] viral load 12 (n) 8 (n) Xiannuoxin COVID-19 outcomes February 2024 Favors xiannuoxin Favors control
Figure S1. All outcomes.
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop